Skip to main content
SABS logo

SABS · SAB Biotherapeutics, Inc. · Webcasts, Transcripts & Audio

Track SABS — free
$3.16 +0.09 (+2.93%) Q2 2026 earnings call transcript
Market Cap
$285.96M
Shares
90.99M
Volume · Oct 28 81.26K Avg daily vol (3M) 528.92K

SAB Biotherapeutics, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for SAB Biotherapeutics, Inc. (SABS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Key facts CIK 1833214 CUSIP 78397T202 13F (30d) 8 filings 8 filers Visit website Investor relations